Centre for Optimum Health — Inflammatory & Metabolic Medicine | Dr. Anupam Gaur, Gurugram
Centre for Optimum Health · Gurugram
The other overlooked half of your treatment

You have been treated.
But have you been healed?

Every year, millions of people with diabetes, heart disease, fatty liver, and autoimmune conditions receive excellent treatment — and remain patients for life. Modern medicine addresses the disease event brilliantly. What it rarely addresses is the biological environment that allowed the disease to develop. That environment — the bioterrain — remains unchanged. And so the disease continues, returns, or transforms.

57%
of asymptomatic type 2 diabetics have silent diastolic dysfunction — detectable years before heart failure
Dhingra et al.; Paulus & Tschöpe, JACC 2013
7
distinct biological fates inflammation can take — only one leads to complete healing
Serhan et al., resolution biology
8
terrain axes that determine which fate your inflammation will follow — all measurable, all modifiable
CFOH bioterrain framework
The unsolved question

A cardiac patient remains a cardiac patient.
A cancer survivor remains at risk. Why?

Modern medicine excels at managing disease events — stents, insulin, chemotherapy, anti-inflammatory drugs. What it rarely addresses is the underlying biological environment that allowed the disease to develop. That environment remains unchanged after treatment. And so the disease continues, worsens, or re-emerges in a new form.

This is not a criticism of conventional medicine. It is a description of its boundary — the point where its tools end and where bioterrain medicine begins.

“The same inflammation, in two different patients, can resolve cleanly in one — and silently destroy the other over a decade. The difference is not the disease. It is the terrain in which it is burning.”

— Dr. Anupam Gaur, Founder, Centre for Optimum Health
Two halves of the same problem

Your treatment addresses one half.
CFOH addresses the other.

Think of it as two complementary lenses on the same body. Both are necessary. Neither is sufficient alone.

Conventional medicine addresses
The disease event
Organ-level damage
Symptoms and biomarker control
Blood sugar, blood pressure, cholesterol
Heart attacks, cancer, acute episodes
Pharmaceutical suppression of disease pathways
Emergency intervention and surgical correction
The other overlooked half — CFOH addresses
The biological terrain
Mitochondrial function and cellular energy
Inflammation resolution capacity
Microvascular density and tissue perfusion
Senescent cell burden and SASP signalling
Metabolic flexibility and insulin signalling
Regenerative biology and recovery capacity

Controlling blood sugar does not reverse mitochondrial dysfunction.
Lowering cholesterol does not clear senescent cells.
Managing blood pressure does not restore microvascular density.
These are different problems — and they require a different kind of attention.

+
This is not about replacing your cardiologist, endocrinologist, or oncologist.
Dr. Gaur works alongside your existing specialists — not instead of them. Your cardiologist manages your cardiac events. Your oncologist manages your cancer treatment. CFOH addresses what neither speciality, by design, was trained to address: the biological terrain that allowed those diseases to develop — and that, if left unchanged, ensures they continue or return. Two different jobs. Both necessary. One has been missing.
The core concept

What is bioterrain?

Your bioterrain is the internal biological environment your cells live in. Think of it like soil: the same seed in depleted soil and rich soil produces entirely different plants. Your cells respond to their environment in exactly the same way. The eight terrain axes below determine whether inflammation resolves cleanly — or quietly destroys.

1
Mitochondrial biogenesis
Your cellular power plants. When they fail, inflammation cannot resolve — damaged cells survive instead of clearing, seeding chronic disease and accelerated ageing. Dysfunctional mitochondria are the root driver of the apoptosis-to-senescence shift.
2
Metabolic flexibility
The ability to switch between glucose and fat as fuel. Insulin resistance and metabolic inflexibility keep NF-κB — the master switch of inflammation — chronically active. This converts acute protective inflammation into slow, smouldering, systemic destruction.
3
Microcirculation
The density and function of your smallest blood vessels. Microvascular rarefaction — the silent loss of capillary density — starves tissues of oxygen and traps inflammatory debris, driving fibrosis and organ degeneration long before symptoms appear.
4
Autophagy
The cellular cleanup system. When it fails, damaged and senescent “zombie cells” accumulate and release SASP — a toxic inflammatory secretion (IL-6, TNF-α, MMPs) that spreads damage to neighbouring cells and perpetuates chronic disease loops.
5
Immune regulation
Precision versus overreaction. A dysregulated immune terrain turns protective inflammation into autoimmunity, cancer-permissive microenvironments, or persistent multi-system inflammatory loops. Restoring precision is not immunosuppression — it is terrain repair.
6
Body composition
VAT/SAT ratio >0.4, sarcopenia, and loss of lean mass are not aesthetic concerns — they are bioterrain markers predicting cardiovascular events, neurodegeneration, and mortality. Visceral fat actively secretes pro-inflammatory cytokines. Muscle is the body’s primary metabolic organ.
7
Epigenetic reformation
The biological age of your cells — shaped by stress, sleep quality, environmental toxin burden, and circadian rhythm. Biological age can diverge significantly from chronological age, in either direction. Unlike genetics, epigenetic state is measurable and modifiable.
8
Microbial restoration
Gut-derived endotoxemia — LPS leakage from a compromised microbiome — is a primary driver of chronic NF-κB activation and systemic inflammation. The gut-immune axis is one of the most powerful and overlooked terrain levers in chronic disease.
The central clinical framework

The seven fates of inflammation

Inflammation is not the enemy. Unresolved inflammation is. Depending on the state of your bioterrain, the same inflammatory trigger can travel down seven very different biological paths. Only one leads back to health. Select each fate to understand the clinical picture.

Select any outcome above to see the clinical picture and the terrain factors that drive it.
Detection before symptoms

Bioterrain markers that reveal the future —
years before diagnosis

Standard health checks detect disease. Bioterrain assessment detects trajectory. These five markers appear in routine or advanced investigations — but are rarely interpreted as terrain signals. Each one is a window into where your biology is heading.

Select a marker above to see its clinical significance.

Getting started

How it works — step by step

The CFOH process is structured, personalised, and complementary to your existing medical care. It begins with a thorough clinical conversation and ends with a bespoke optimisation plan built around your specific bioterrain state.

1
Initial Consultation
You begin by booking a consultation with Dr. Gaur. Your full medical history, symptoms, current medications, health concerns, and overall condition are reviewed in depth. Based on this assessment, specific diagnostic tests and bioterrain investigations are recommended.
2
Diagnostic Evaluation
Once the recommended investigations are completed and reports are available, a second consultation is scheduled. Tests may include bioterrain markers such as diastolic function assessment, body composition analysis, metabolic panels, and inflammatory markers — tailored to your clinical picture.
3
Personalised Optimisation Plan
Dr. Gaur reviews your results, develops a detailed understanding of your current terrain state, and delivers a personalised plan — addressing the root biological causes of your condition, not only its symptoms or measurements.
The optimisation plan may include any combination of the following:
Lifestyle modifications and health management strategies tailored to your terrain axes
Targeted natural health products and evidence-based supplementation
Repurposed medications where appropriate and evidence-supported
Conventional medical treatments or specialist referrals if required

“Our goal is to identify the root causes of health concerns and create a customised plan to optimise your overall well-being. Through this approach, we help patients achieve a better healthspan alongside a longer lifespan.”

— Centre for Optimum Health
Transparent pricing

Cost structure

The total cost varies from patient to patient and depends on the stage of your condition, current health status, the investigations required, and the extent of optimisation needed. The overall programme typically includes two doctor consultations, recommended investigations, and a personalised treatment plan.

Component Cost
Doctor Consultation ₹2,500 per consultation
Investigations & Diagnostic Tests Varies by individual — determined after initial consultation
Treatment Plan & Optimisation Protocol Varies by individual — determined after diagnostic evaluation
The standard programme includes two consultations — an initial clinical review and a follow-up to discuss investigations and deliver the personalised plan. All costs are discussed transparently before any tests or protocols are initiated.
➤  Book a Consultation

Initial consultation: ₹2,500 · Centre for Optimum Health, Gurugram

You optimise your portfolio. Your schedule.
Your performance. You have optimised everything
except the one asset that cannot be replaced.

Your biology is the foundation of every other optimisation you will ever make. It deserves the same rigour.

Begin here

Begin with a bioterrain assessment

A structured evaluation of the eight terrain axes — designed for high-functioning individuals who want to understand not just their current health, but where it is going.

➤  Book a Consultation
AG
Dr. Anupam Gaur
Founder, Centre for Optimum Health · Gurugram
Specialist in Inflammatory & Metabolic Disorders
Scientific references: Paulus WJ & Tschöpe C, JACC 2013 (HFpEF/microvascular paradigm) · Serhan CN et al. (specialised pro-resolving mediators / resolution biology) · Campisi J et al. (senescence, SASP) · Mocan M et al., Dis Markers 2019 (inflammatory biomarkers in diastolic dysfunction) · Dhingra A et al. (LVDD prevalence in T2DM) · Kane GC et al., JAMA 2011 (diastolic dysfunction progression).

The content on this page is for health awareness and education. It does not constitute medical advice and is intended to complement, not replace, care from your treating physician. Always consult a qualified healthcare professional before making changes to your treatment or health management plan.